Edition:
United States

Profile: UMN Pharma Inc (4585.T)

4585.T on Tokyo Stock Exchange

290JPY
19 Sep 2017
Change (% chg)

¥2 (+0.69%)
Prev Close
¥288
Open
¥289
Day's High
¥294
Day's Low
¥289
Volume
92,100
Avg. Vol
569,711
52-wk High
¥1,532
52-wk Low
¥225

UMN Pharma Inc. is a Japan-based biotechnology company mainly engaged in the biopharmaceuticals development business. The Company is engaged in the development, manufacture and sale of biopharmaceuticals based on the baculovirus expression vector system (BEVS) manufacturing platform. The Company's pipelines include seasonal influenza vaccine UMN-0502, pandemic influenza vaccine UMN-0501, pandemic influenza vaccine UMN-0901 and norovirus/rotavirus vaccine UMN-2003. As of December 31, 2012, the Company had one consolidated subsidiary.

Company Address

UMN Pharma Inc

26F, Yokohama Landmark Tower
2-2-1, Minato Mirai, Nishi-ku
YOKOHAMA-SHI   KNG   222-0033
P: +8145.5959840
F: +8145.5959845

Company Web Links